Recent Updates

Published: 
Aug 16, 2018
Chapter 18

Platelets are the smallest of the blood cells, with a diameter of two to three microns and no nucleus. Their main function is to mediate primary hemostasis, though they are involved in a number of other processes including primary immunity, tumour progression and inflammation. 

Transfusion
Published: 
Aug 17, 2018
Chapter 17

Abnormal bleeding may result from defects in platelets, coagulation factors and/or blood vessels. Screening tests for coagulation factor abnormalities include the activated Partial Thromboplastin Time (aPTT) and Prothrombin Time (PT) / International Normalized Ratio (INR). Thrombocytopenia is the most common platelet defect. Qualitative platelet defects may also occur and, in some cases, may be associated with thrombocytopenia. In patients with platelet defects, bleeding time and/or closure times using the platelet function analyzer (PFA-100/200TM) may be prolonged. Vascular defects may be accompanied by joint hyperflexibility or skin laxity. Effective treatment of hemostatic disorders requires accurate diagnosis and special coagulation testing that may include coagulation factor assays, inhibitor assays, and platelet function tests. An algorithmic approach to diagnosis is beyond the scope of this review.

Transfusion
Published: 
Aug 10, 2018
Chapter 4

Immune globulin (Ig) products are generated from plasma collected from a large number of carefully screened donors. Ig products may be used as replacement therapy for immunodeficiency patients or as immunomodulatory therapy for autoimmune and alloimmune disorders. Ig products include intravenous Ig (IVIg), subcutaneous Ig (SCIg), RhD Ig (RhIg) and hyperimmune globulins.

Transfusion

Upcoming Events

When
October 13, 2018 | 8:00AM to October 16, 2018 | 6:00PM
Where

Boston, MA

The AABB Annual Meeting is the premiere event for healthcare professionals in the fields of transfusion medicine and cellular therapies.

Click here for more information.

Transfusion
Stem Cells
When
November 16, 2018 | 8:00AM to November 17, 2018 | 6:00PM
Where

Edmonton

The purpose of the conference is to bring together multiple voices to support and build inclusive an equitable teaching and learning environments for medical staff, sickle cell disease patients, their families, first responders the public and other stakeholders. The event will be targeted towards physicians, surgeons, researchers and other medical practitioners within the community committed to finding a cure for Sickle Cell Anemia and more knowledge of the continued effects of sickle cell anemia trait.

Transfusion
Stem Cells
When
September 21, 2018 | 8:45AM to 4:00PM
Where

Lethbridge

All are welcome to join the Chinook Regional Hospital Transfusion Medicine Department for our Canadian Society for Transfusion Medicine (CSTM) Education Day September 21, 2018!
A variety of speakers will be discussing logistics and management of Mass Transfusions and Causalities in rural hospital settings.

Transfusion

Blog

Modified on: 
Aug 14, 2018

BloodTechNet is a competitive funding program that supports projects aimed at delivering innovative educational resources for healthcare professionals in the transfusion, cellular therapy, and transplantation communities.  

Modified on: 
Jul 30, 2018

This week, we chat with Canadian Blood Services’ adjunct scientist, Dr. Elisabeth Maurer, about her work to understand blood platelets for transfusion, the technology she has developed to help determine “what’s in the bag”, and what inspires her to keep researching these small but dynamic cell fragments that are so critical to bleeding, clotting, and the immune system.

ISBT transfusion medicine education

Modified on: 
Jul 22, 2018

At the 35th Congress of the International Society for Blood Transfusion (ISBT), members of our network gathered to share their knowledge and exciting new educational resources.